ReviewCancer drug resistance (Alhambra, Calif.)2021

Oxidative stress and redox signaling in CRPC progression: therapeutic potential of clinically-tested Nrf2-activators.

Debasis Mondal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.